350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

80+ case studies, solution & technology presentations & 2 interactive workshops over the 2 days.

07 April 2019 – Day One

• Genome Editing Technologies & Techniques
• Drug Discovery & Development Applications in In Vivo Therapeutics

08 April 2019 – Day Two

• Drug Discovery & Development – Target Identification and Validation
• Non-Human Models in Diagnostics & Therapeutics

View Agenda: http://bit.ly/2rLMzeL

2020 Live Webinar

Chemically-Modified Polynucleotides for Inhibiting, Expressing and Repairing Nucleic Acids: Then & Now

Presented by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.

Tuesday, 10 March 2020 | 03:30 PM GMT

Register: https://bit.ly/2QvO7Us